Venosafe
Venosafe is a laboratory blood collection device designed for healthcare professionals. It is used to collect blood samples from patients in a safe and efficient manner.
Lab products found in correlation
12 protocols using venosafe
Collection of Blood Samples from Healthy Donors
Blood Cytokine Production Assay
Venous Blood Sampling for Lipid and Thyroid Assays
All basic assays were performed at the Laboratory of Analytical Biochemistry at the National Public Health Institute, Helsinki (Disease Risk Unit, Institute for Health and Welfare since 2009), using an ARCHITECT ci8200 analyzer (Abbott Laboratories). High-sensitivity C-reactive protein (hs-CRP) was measured with an ultrasensitive immunoturbidimetric method using Abbott architect reagents.
Free thyroxine (F-T4), free triiodothyronine (F-T3), and thyroid stimulating hormone (TSH) were measured from frozen EDTA-plasma samples with Cobas e601 (Roche Diagnostics) automated analyzer in the Islab Laboratory of the University of Eastern Finland, Kuopio, in the year 2013. The reference values for free T4, free T3, and TSH were 11–22 pmol/L, 3.1–6.8 pmol/L, and 0.3–4.2 mU/L, respectively. Serum thyroid antiperoxidase antibodies were measured by Architect® (Abbott Laboratories) automated analyzer. Analytical sensitivity of the assay was 0.16 IU/mL. The upper reference limit was 6.0 IU/mL.
Minimally Invasive Animal Sampling
Monitoring Chemotherapy Response in Lymphoma
Terumo, Leuven, Belgium) at patient catheter. Samples were obtained at the
administration of the first chemotherapeutic cure (C0) (just before
administration), at the administration of the second and the fourth cycles of
chemotherapy (C2 and C4), and at the remission review (Cf). In the case of an
autograft, a final sample was taken at the postgraft review. These times were
chosen considering the evaluation of the response to treatment performed by 18 (link)fluorodeoxyglucose positron emission tomography (FDG-PET)/computed
tomography (CT) during the fourth chemotherapeutic cure. The patient response
was evaluated using the Deauville score21 (link) and according to the Lugano classification.22 (link) Platelet-free plasma was obtained following strict pre-analytical setting
already published by our research group.23 (link) Plasma samples were frozen in liquid nitrogen and stored at −80°C.
Assessment of Antigen-Specific T Cell Response
Metabolic Biomarker Profiling Protocol
The sensitivity and inter-assay coefficient of variation for these assays were: 0.2 ng/ml, 6.1% for leptin; 0.6 pg/ml, 17.3% for ghrelin; 2.32 μmol/l, 2.2% for creatinine; 0.1 mmol/l; 3.8% for glucose; 1.1 mmol/l, 5.8% for urea, 10 μmol/l, 5.8% for free fatty acids; 100 mmol/l, 0.7% for sodium; 2 mmol/l, 2.5% for potassium and 55 mmol/l, 3.3% for chloride.
Plasma and Serum Biomarker Analysis
Plasma 25(OH) D levels were measured using a 25-OH Vitamin D (direct) ELISA kit (PromoKine, France) according to the manufacturer’s instructions.
Serum calcium and phosphorus levels were measured using an automat Konelab 20 (Thermo Scientific, MA, United States).
PRP Preparation for Dasatinib Patients
Blood was taken 3 and 24 h after drug administration, corresponding to the expected peak of dasatinib in peripheral blood. Concerning the patients characteristics, the mean time from diagnosis of chronic myeloid leukemia (CML) in chronic phase was 25,5 months (range 6–60). All the patients discontinued treatment with imatinib due to adverse reaction or treatment failure and were on treatment with dasatinib (100 mg/day in four patients, 140 mg/day in one patient) from 9 months (range 2–32). In all subjects blood was drawn by venepuncture into 3,6 ml vacutainer (Venosafe, Terumo) with trisodium citrate 0.109
Platelet-rich plasma was obtained by centrifugation of blood at 200 × g at room temperature for 10 min and platelet count was estimated by an automated cell counter.
Fasting Blood Hormone Analysis
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!